Anti-infective immunotherapy

Adoptive leukocyte immunotherapy. Extracorporeal leukocyte priming (instructing or programming) dramatically increases leukocyte migration and microbicidal activity . Adoptive leukocyte immunotherapy has been convincingly shown to be an effective method for treating chronic viral diseases, as well as antibiotic-resistant bacterial infections (Chernykh et al., 2006).

Drug-based immunotherapy sserves as an additive treatment to support anti-infective capacity of patient's immune defense.

Diseases:

• Infectious lung diseases
• Chronic cystitis
• Sinusitis
• Bacterial wound infections
• Herpes virus infection
• Papilloma virus infection

Indications for immunotherapy:

• Frequent relapses of the disease

• Inefficiency or insufficient effectiveness of standard treatment.

Contraindications for immunotherapy:

• Severe anemia
• Multiple organ failure.

Advantages and benefits of anti-infective immunotherapy:

• Discontinuation of drug intake or reduction of the drug burden.
• The achievement of pronounced clinical effects in the vast majority of patients.
• No serious side effects.
• Repeated courses of therapy are possible and feasible upon disease relapses.
• The availability of multiple combination options with other therapeutic interventions, including physiotherapy.